BIOMARKER:

Chr del(13q)

Chr del(13q) Chr del(13q)	Multiple Myeloma Multiple Myeloma	Chr del(13q) Chr del(13q)	Multiple Myeloma Multiple Myeloma	bortezomib Resistant: C3 – Early Trials	bortezomib Resistant: C3 – Early Trials
Chr del(13q) Chr del(13q)	Chronic Lymphocytic Leukemia CLL	Chr del(13q) Chr del(13q)	Chronic Lymphocytic Leukemia CLL	BMF-219 Sensitive: D – Preclinical	BMF-219 Sensitive: D – Preclinical

Associations